Declan Quinn
Declan Quinn
Professor of Psychiatry, University of Saskatchewan
Verified email at saskatoonhealthregion.ca
TitleCited byYear
Enantioselective pharmacokinetics and pharmacodynamics of dlthero‐mcthylphenidate in children with attention deficit hyperactivity disorder
NR Srinivas, JW Hubbard, D Quinn, KK Midha
Clinical Pharmacology & Therapeutics 52 (5), 561-568, 1992
1591992
Efficacy and safety of Ritalin® LA™, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder
J Biederman, D Quinn, M Weiss, S Markabi, M Weidenman, K Edson, ...
Pediatric Drugs 5 (12), 833-841, 2003
1012003
Enantioselective aspects of the disposition of dl‐threo‐methylphenidate after the administration of a sustained‐release formulation to children with attention deficit …
JW Hubbard, NR Srinivas, D Quinn, KK Midha
Journal of pharmaceutical sciences 78 (11), 944-947, 1989
801989
Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d, l-threo …
D Quinn, S Wigal, J Swanson, S Hirsch, Y Ottolini, M Dariani, M Roffman, ...
Journal of the American Academy of Child & Adolescent Psychiatry 43 (11 …, 2004
762004
Stereoselective disposition of methylphenidate in children with attention-deficit disorder.
NR Srinivas, D Quinn, JW Hubbard, KK Midha
Journal of Pharmacology and Experimental Therapeutics 241 (1), 300-306, 1987
751987
Oppositional defiant disorder is better conceptualized as a disorder of emotional regulation
M Cavanagh, D Quinn, D Duncan, T Graham, L Balbuena
Journal of attention disorders 21 (5), 381-389, 2017
652017
Comparison of the clinical efficacy of twice-daily Ritalin® and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder
RL Findling, D Quinn, SJ Hatch, SJ Cameron, HH DeCory, M McDowell
European child & adolescent psychiatry 15 (8), 450-459, 2006
612006
Single‐dose pharmacokinetics of multilayer‐release methylphenidate and immediate‐release methylphenidate in children with attention‐deficit/hyperactivity disorder
D Quinn, MT Bode, JL Reiz, GAE Donnelly, AC Darke
The Journal of Clinical Pharmacology 47 (6), 760-766, 2007
592007
Canadian ADHD practice guidelines
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)
CADDRA, 2011
562011
The Capgras syndrome: two case reports and a review
D Quinn
The Canadian Journal of Psychiatry 26 (2), 126-129, 1981
401981
Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans
NR Srinivas, JW Hubbard, D Quinn, ED Korchinski, KK Midha
Progress in Neuro-Psychopharmacology and Biological Psychiatry 15 (2), 213-220, 1991
351991
Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder
M Weiss, L Hechtman, A Turgay, U Jain, D Quinn, TS Ahmed, T Yates, ...
Journal of Child and Adolescent Psychopharmacology 17 (5), 675-688, 2007
262007
Prevalence of Psychoactive Medication in Children and Adolescents
DMP Quinn
The Canadian Journal of Psychiatry 31 (6), 575-580, 1986
241986
Does chirality matter?: Pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder
D Quinn
Journal of clinical psychopharmacology 28 (3), S62-S66, 2008
222008
Psychiatric human resources planning in Canada
JK Sargeant, T Adey, F McGregor, P Pearce, D Quinn, R Milev, S Renaud, ...
Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie 6, 2010
192010
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines
U Jain, L Hechtman, D Quinn, A Turgay, J Yaremko, C Mutch
Toronto, Ontario: CADDRA, 2006
172006
Canadian rural/remote primary care physicians perspectives on child/adolescent mental health care service delivery
R Zayed, B Davidson, L Nadeau, TS Callanan, W Fleisher, L Hope-Ross, ...
Journal of the Canadian Academy of Child and Adolescent Psychiatry 25 (1), 24, 2016
112016
Advances in ADHD treatment
JR Leroux, A Turgay, D Quinn
Can J Diagn 26, 49-52, 2009
72009
A phase-2 pharmacokinetic study of a modified release formulation of dextroamphetamine following evening administration to adolescents and children with ADHD
D Quinn, T Bode, NJ DeSousa
American Professional Society of ADHD and Related Disorders Annual Meeting …, 2015
32015
A Measure of Emotional Regulation and Irritability in Children and Adolescents: The Clinical Evaluation of Emotional Regulation–9
J Pylypow, D Quinn, D Duncan, L Balbuena
Journal of attention disorders, 1087054717737162, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20